Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance

Journal of Nutritional Biochemistry

Volumn 21, Issue 5, 2010, Pages 364-373

  Su, Hui Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Aged; Alzheimer's disease; Brain; Docosahexaenoic acid; Eicosapentaenoic acid; Estrogen; Hippocampus; Learning memory; N 3 fatty acids; Neurogenesis; Retinoid signaling; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESTROGEN; F ACTIN; GLUTAMATE RECEPTOR 1; ICOSAPENTAENOIC ACID; MYELIN; NEUROMODULIN; OMEGA 3 FATTY ACID; PHOSPHATIDYLETHANOLAMINE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN C FOS; RETINOID; SYNAPSIN I; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL COUNT; COGNITIVE DEFECT; DENDRITIC SPINE; DIET SUPPLEMENTATION; HIPPOCAMPUS; HUMAN; INHIBITION KINETICS; LEARNING; LONG TERM POTENTIATION; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTOGENESIS; TASK PERFORMANCE;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; ESTROGENS; FATTY ACIDS, OMEGA-3; FETAL DEVELOPMENT; HUMANS; LEARNING; MEMORY; NEUROGENESIS; NEURONAL PLASTICITY; NEURONS; NEUROPROTECTIVE AGENTS; TASK PERFORMANCE AND ANALYSIS;

RATTUS;

EID: 77951620202     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.11.003     Document Type: Review

References (138)

1. Fedorova I., Salem N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids 2006, 754-5:271-289.
2. Sastry P.S. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985, 242:69-176.
3. Rapoport SI In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 2001, 162-3:243-261. [discussion 79-84].
4. Aid S., Vancassel S., Poumes-Ballihaut C., Chalon S., Guesnet P., Lavialle M. Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 2003, 448:1545-1551.
5. Ahmad A., Murthy M., Greiner R.S., Moriguchi T., Salem N. A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus. Nutr Neurosci 2002, 52:103-113.
6. Puskas L.G., Kitajka K., Nyakas C., Barcelo-Coblijn G., Farkas T. Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A 2003, 1004:1580-1585.
7. Novak E.M., Dyer R.A., Innis S.M. High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 2008, 1237:136-145.
8. Wurtman R.J., Ulus I.H., Cansev M., Watkins C.J., Wang L., Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 2006, 10881:83-92.
9. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979, 31:79-83.
10. Green P., Glozman S., Kamensky B., Yavin E. Developmental changes in rat brain membrane lipids and fatty acids. The preferential prenatal accumulation of docosahexaenoic acid. J Lipid Res 1999, 405:960-966.
11. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992, 1204(Pt 2):S129-S138.
12. Favreliere S., Stadelmann-Ingrand S., Huguet F., De Javel D., Piriou A., Tallineau C., et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging 2000, 215:653-660.
13. Delion S., Chalon S., Guilloteau D., Lejeune B., Besnard J.C., Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 1997, 384:680-689.
14. Soderberg M., Edlund C., Kristensson K., Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991, 266:421-425.
15. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 1998, 231:81-88.
16. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005, 11510:2774-2783.
17. Moser M.B., Moser E.I. Functional differentiation in the hippocampus. Hippocampus 1998, 86:608-619.
18. de Hoz L., Knox J., Morris R.G. Longitudinal axis of the hippocampus: both septal and temporal poles of the hippocampus support water maze spatial learning depending on the training protocol. Hippocampus 2003, 135:587-603.
19. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 2975868:681-683.
20. Chung W.L., Chen J.J., Su H.M. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 2008, 1386:1165-1171.
21. Tully A.M., Roche H.M., Doyle R., Fallon C., Bruce I., Lawlor B., et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003, 894:483-489.
22. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 111:47-60.
23. Whelan J., Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr 2006, 26:75-103.
24. Su H.M., Moser A.B., Moser H.W., Watkins P.A. Peroxisomal straight-chain Acyl-CoA oxidase and d-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis. J Biol Chem 2001, 27641:38115-38120.
25. Scott B.L., Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci U S Am 1989, 868:2903-2907.
26. Su H.M., Huang M.C., Saad N.M., Nathanielsz P.W., Brenna J.T. Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo. A stable isotope tracer study. J Lipid Res. 2001, 424:581-586.
27. Green P., Yavin E. Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo. J Lipid Res 1993, 3412:2099-2107.
28. Cook H.W. In vitro formation of polyunsaturated fatty acids by desaturation in rat brain: some properties of the enzymes in developing brain and comparisons with liver. J Neurochem 1978, 306:1327-1334.
29. Bourre J.M., Piciotti M., Dumont O. Delta 6 desaturase in brain and liver during development and aging. Lipids 1990, 256:354-356.
30. Su H.M., Bernardo L., Mirmiran M., Ma X.H., Corso T.N., Nathanielsz P.W., et al. Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr Res 1999, 451:87-93.
31. Bowen R.A., Wierzbicki A.A., Clandinin M.T. Does increasing dietary linolenic acid content increase the docosahexaenoic acid content of phospholipids in neuronal cells of neonatal rats?. Pediatr Res 1999, 456:815-819.
32. Bourre J.M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 1989, 11912:1880-1892.
33. Salem N., Wegher B., Mena P., Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S Am 1996, 931:49-54.
34. Umhau J.C., Zhou W., Carson R.E., Rapoport S.I., Polozova A., Demar J., et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 2009, 507:1259-1268.
35. Williams C.M., Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 2006, 651:42-50.
36. Francois C.A., Connor S.L., Bolewicz L.C., Connor W.E. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003, 771:226-233.
37. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 802-3:85-91.
38. Shindou H., Shimizu T. Acyl-CoA:lysophospholipid acyltransferases. J Biol Chem 2009, 2841:1-5.
39. Vergnes L., Beigneux A.P., Davis R., Watkins S.M., Young S.G., Reue K. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 2006, 474:745-754.
40. Cao J., Shan D., Revett T., Li D., Wu L., Liu W., et al. Molecular identification of a novel mammalian brain isoform of acyl-CoA:lysophospholipid acyltransferase with prominent ethanolamine lysophospholipid acylating activity, LPEAT2. J Biol Chem. 2008, 28327:19049-19057.
41. Ginsberg L., Rafique S., Xuereb J.H., Rapoport S.I., Gershfeld N.L. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res 1995, 6981-2:223-226.
42. Guan Z., Wang Y., Cairns N.J., Lantos P.L., Dallner G., Sindelar P.J. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol 1999, 587:740-747.
43. Farooqui A.A., Rapoport S.I., Horrocks L.A. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurochem Res 1997, 224:523-527.
44. Kaduce T.L., Chen Y., Hell J.W., Spector A.A. Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons. J Neurochem 2008.
45. Marszalek J.R., Kitidis C., Dararutana A., Lodish H.F. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J Biol Chem 2004, 27923:23882-23891.
46. Marszalek J.R., Kitidis C., Dirusso C.C., Lodish H.F. Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J Biol Chem 2005, 28011:10817-10826.
47. Wu H., Ichikawa S., Tani C., Zhu B., Tada M., Shimoishi Y., et al. Docosahexaenoic acid induces ERK1/2 activation and neuritogenesis via intracellular reactive oxygen species production in human neuroblastoma SH-SY5Y cells. Biochim Biophys Acta 2009, 17911:8-16.
48. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 2004, 904:979-988.
49. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., et al. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009, 1112:510-521.
50. Cao D., Xue R., Xu J., Liu Z. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem 2005, 169:538-546.
51. Kan I., Melamed E., Offen D., Green P. Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. J Lipid Res 2007, 483:513-517.
52. He C., Qu X., Cui L., Wang J., Kang J.X. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S Am 2009, 10627:11370-11375.
53. Salvati S., Natali F., Attorri L., Di Benedetto R., Leonardi F., Di Biase A., et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res 2008, 864:776-784.
54. Ahmad A., Moriguchi T., Salem N. Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol 2002, 263:210-218.
55. Wang PY, Chen JJ, Su HM Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein42 and upregulates cytoskeletal protein expression. J Nutr Biochem 2009, accepted.
56. Contreras M.A., Greiner R.S., Chang M.C., Myers C.S., Salem N., Rapoport S.I. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J Neurochem 2000, 756:2392-2400.
57. Diau G.Y., Hsieh A.T., Sarkadi-Nagy E.A., Wijendran V., Nathanielsz P.W., Brenna J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med 2005, 3:11.
58. Moriguchi T., Greiner R.S., Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000, 756:2563-2573.
59. Lim S.Y., Hoshiba J., Moriguchi T., Salem N. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr Res 2005, 584:741-748.
60. Moriguchi T., Salem N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 2003, 872:297-309.
61. Matsuzaki M., Honkura N., Ellis-Davies G.C., Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 2004, 4296993:761-766.
62. Mizuno K., Giese K.P. Hippocampus-dependent memory formation: do memory type-specific mechanisms exist?. J Pharmacol Sci 2005, 983:191-197.
63. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 3616407:31-39.
64. Kawashima A., Harada T., Kami H., Yano T., Imada K., Mizuguchi K. Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J Nutr Biochem 2009.
65. Fujita S., Ikegaya Y., Nishikawa M., Nishiyama N., Matsuki N. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol 2001, 1327:1417-1422.
66. Wu A., Ying Z., Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 1553:751-759.
67. Sakamoto T., Cansev M., Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 2007, 1182:50-59.
68. Tanabe Y., Hashimoto M., Sugioka K., Maruyama M., Fujii Y., Hagiwara R., et al. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol 2004, 3110:700-703.
69. Cansev M., Wurtman R.J. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 2007, 1482:421-431.
70. Cansev M., Wurtman R.J., Sakamoto T., Ulus I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement 2008, 41(Suppl 1):S153-S168.
71. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., et al. Docosahexaenoic Acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 435:633-645.
72. Kaplan M.S., Bell D.H. Mitotic neuroblasts in the 9-day-old and 11-month-old rodent hippocampus. J Neurosci 1984, 46:1429-1441.
73. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J Neurosci 2002, 223:629-634.
74. Eckenhoff M.F., Rakic P. Nature and fate of proliferative cells in the hippocampal dentate gyrus during the life span of the rhesus monkey. J Neurosci 1988, 88:2729-2747.
75. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 1998, 411:1313-1317.
76. Bruel-Jungerman E., Davis S., Rampon C., Laroche S. Long-term potentiation enhances neurogenesis in the adult dentate gyrus. J Neurosci 2006, 2622:5888-5893.
77. Drapeau E., Mayo W., Aurousseau C., Le Moal M., Piazza P.V., Abrous D.N. Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S Am 2003, 10024:14385-14390.
78. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 4106826:372-376.
79. Coti Bertrand P., O'Kusky J.R., Innis S.M. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr 2006, 1366:1570-1575.
80. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 1393:991-997.
81. Kim H.Y., Akbar M., Lau A., Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem. 2000, 27545:35215-35223.
82. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S Am 2005, 10231:10858-10863.
83. Akbar M., Kim H.Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 2002, 823:655-665.
84. Rotstein N.P., Politi L.E., German O.L., Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003, 445:2252-2259.
85. Rotstein N.P., Aveldano M.I., Barrantes F.J., Roccamo A.M., Politi L.E. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 1997, 692:504-513.
86. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000, 198:1784-1793.
87. Lonergan P.E., Martin D.S., Horrobin D.F., Lynch M.A. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J Biol Chem 2002, 27723:20804-20811.
88. Bas O., Songur A., Sahin O., Mollaoglu H., Ozen O.A., Yaman M., et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 2007, 503:548-554.
89. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004, 2110:1457-1467.
90. Dyall S.C., Michael G.J., Whelpton R., Scott A.G., Michael-Titus A.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging 2007, 283:424-439.
91. McGahon B.M., Martin D.S., Horrobin D.F., Lynch M.A. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 1999, 941:305-314.
92. Martin D.S., Spencer P., Horrobin D.F., Lynch M.A. Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. Prostaglandins Leukot Essent Fatty Acids 2002, 672-3:121-130.
93. Nacher J., Alonso-Llosa G., Rosell D.R., McEwen B.S. NMDA receptor antagonist treatment increases the production of new neurons in the aged rat hippocampus. Neurobiol Aging 2003, 242:273-284.
94. Markham J.A., Juraska J.M. Aging and sex influence the anatomy of the rat anterior cingulate cortex. Neurobiol Aging 2002, 234:579-588.
95. Jacobs B., Driscoll L., Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. The Journal of comparative neurology 1997, 3864:661-680.
96. O'Donnell E., Vereker E., Lynch M.A. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. The European journal of neuroscience 2000, 121:345-352.
97. Lynch A.M., Loane D.J., Minogue A.M., Clarke R.M., Kilroy D., Nally R.E., et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging 2007, 286:845-855.
98. Bourre J.M., Dumont O.S., Piciotti M.J., Pascal G.A., Durand G.A. Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes. Biochim Biophys Acta 1992, 11242:119-122.
99. Favreliere S., Perault M.C., Huguet F., De Javel D., Bertrand N., Piriou A., et al. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging 2003, 242:233-243.
100. Teather L.A., Wurtman R.J. Dietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging rats. Progress in neuro-psychopharmacology & biological psychiatry 2003, 274:711-717.
101. Barcelo-Coblijn G., Hogyes E., Kitajka K., Puskas L.G., Zvara A., Hackler L., et al. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S Am 2003, 10020:11321-11326.
102. Gamoh S., Hashimoto M., Hossain S., Masumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 2001, 284:266-270.
103. Mulder C., Scheltens P., Visser J.J., van Kamp G.J., Schutgens R.B. Genetic and biochemical markers for Alzheimer's disease: recent developments. Ann Clin Biochem 2000, 37(Pt 5):593-607.
104. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S Am 2002, 999:6364-6369.
105. Spires T.L., Hyman B.T. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2005, 23:423-437.
106. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997, 184:351-357.
107. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 2006, 962:385-395.
108. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005, 2512:3032-3040.
109. Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007, 2716:4385-4395.
110. Hashimoto M, Hossain S, Tanabe Y, Kawashima A, Harada T, Yano T, et al. The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta((1-40)). J Nutr Biochem 2009, [in press].
111. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005, 1353:549-555.
112. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 2002, 815:1084-1091.
113. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006, 6310:1402-1408.
114. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., Folsom A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007, 854:1103-1111.
115. Whalley L.J., Deary I.J., Starr J.M., Wahle K.W., Rance K.A., Bourne V.J., et al. n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr. 2008, 872:449-454.
116. Boudrault C., Bazinet R.P., Ma D.W. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 2009, 201:1-10.
117. Bakewell L., Burdge G.C., Calder P.C. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 2006, 961:93-99.
118. Crowe F.L., Skeaff C.M., Green T.J., Gray A.R. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 2008, 991:168-174.
119. Giltay E.J., Gooren L.J., Toorians A.W., Katan M.B., Zock P.L. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr 2004, 805:1167-1174.
120. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men?. Br J Nutr 2002, 884:355-363.
121. Burdge G.C., Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002, 884:411-420.
122. Giltay E.J., Duschek E.J., Katan M.B., Zock P.L., Neele S.J., Netelenbos J.C. Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol 2004, 1823:399-408.
123. Sumino H., Ichikawa S., Murakami M., Nakamura T., Kanda T., Sakamaki T., et al. Effects of hormone replacement therapy on circulating docosahexaenoic acid and eicosapentaenoic acid levels in postmenopausal women. Endocr J 2003, 501:51-59.
124. Extier A, Langelier B, Perruchot MH, Guesnet P, Van Veldhoven PP, Lavialle M, et al. Gender affects liver desaturase expression in a rat model of n-3 fatty acid repletion. J Nutr Biochem 2009, [in press].
125. McNamara R.K., Able J., Jandacek R., Rider T., Tso P. Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: Role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 2008.
126. McNamara R.K., Able J., Jandacek R., Rider T., Tso P. Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 2009, 344:532-539.
127. Hojo Y., Murakami G., Mukai H., Higo S., Hatanaka Y., Ogiue-Ikeda M., et al. Estrogen synthesis in the brain-role in synaptic plasticity and memory. Mol Cell Endocrinol 2008, 2901-2:31-43.
128. Frick K.M. Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?. Horm Behav 2009, 551:2-23.
129. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002, 36:433-442.
130. Liu F., Day M., Muniz L.C., Bitran D., Arias R., Revilla-Sanchez R., et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 2008, 113:334-343.
131. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science (New York, NY 2000, 2905499:2140-2144.
132. Misner D.L., Jacobs S., Shimizu Y., de Urquiza A.M., Solomin L., Perlmann T., et al. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S Am 2001, 9820:11714-11719.
133. Jacobs S., Lie D.C., DeCicco K.L., Shi Y., DeLuca L.M., Gage F.H., et al. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci U S Am 2006, 10310:3902-3907.
134. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 1346:921-931.
135. McCaffery P., Zhang J., Crandall J.E. Retinoic acid signaling and function in the adult hippocampus. J Neurobiol 2006, 667:780-791.
136. Lane M.A., Bailey S.J. Role of retinoid signalling in the adult brain. Prog Neurobiol 2005, 754:275-293.
137. Mey J. New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J Neurobiol 2006, 667:757-779.
138. Goodman A.B. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. J Cell Physiol 2006, 2093:598-603.